文献速递胃肠动力与功能性疾病

精准医学时代成人慢性腹泻与腹泻型肠易激综合征的评估

Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
PubMed 文献 · Am J Gastroenterol · 2018-05-01

慢性腹泻常见,年患病率约5%。部分患者有可识别的结构性病因,其余常诊断为腹泻型肠易激综合征(IBS-D)。基于临床标准诊断的IBS-D提示肠道无解剖学改变,但其特异性病理生理机制及对症状管理的改善尚不明确。小肠细菌过度生长、胆汁酸吸收不良、食物不耐受及动力障碍等可能解释IBS-D症状,更有效的检测正在开发,精准医学原则有望带来更快速的诊疗,但目前受限于缺乏足够敏感和特异的检测。

要点

  • 慢性腹泻年患病率约5%,鉴别诊断广泛。
  • 基于临床标准诊断的IBS-D患者肠道多无解剖学改变。
  • IBS-D诊断与特定病理生理机制及症状改善的关系尚不明确。

核心结论

  • 应用精准医学原则(识别特定疾病机制并针对该机制治疗)有望为慢性腹泻包括IBS-D患者带来更快速的诊断和治疗,但目前受限于缺乏足够敏感和特异的、能预测治疗反应的机制检测。

主要发现

  • 慢性腹泻年患病率约5%。
  • 许多慢性腹泻患者有可识别的结构性病变如炎症性肠病或乳糜泻,其他患者常诊断为IBS-D。
  • 基于普遍接受的临床标准,IBS-D诊断识别的是不太可能有肠道解剖学改变疾病的一组患者。
  • 小肠细菌过度生长、胆汁酸吸收不良、食物不耐受及动力障碍等可能解释IBS-D患者的症状。
  • 更有效的检测正在开发,以识别IBS-D背后的临床问题并可能带来更特异的诊断和治疗改善。

局限性

  • 应用精准医学原则目前受限于缺乏足够敏感和特异的、能预测治疗反应的机制检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic diarrhea is a common clinical problem, affecting roughly 5% of the population in any given year. Evaluation and management of these patients can be difficult due to the extensive differential diagnosis of this symptom. Many patients with chronic diarrhea have structural problems, such as inflammatory bowel disease or celiac disease, that can be readily identified. Others do not, and often are given a diagnosis of irritable bowel syndrome with diarrhea (IBS-D). When based on generally accepted clinical criteria, a diagnosis of IBS-D identifies a group of patients who are unlikely to have disorders producing anatomical changes in the gut. It is less clear that a diagnosis of IBS-D identifies a specific pathophysiology or leads to better management of symptoms. Disorders such as small intestinal bacterial overgrowth, bile acid malabsorption, food intolerance, and motility disorders may account for symptoms in patients with IBS-D. More effective tests are being developed to identify the clinical problems underlying IBS-D and may lead to more specific diagnoses that may improve the results of therapy. Application of the principles of precision medicine (identifying a specific mechanism for disease and applying treatments that work on that mechanism) should lead to more expeditious diagnosis and treatment for patients with chronic diarrhea including IBS-D, but currently is limited by the availability of sufficiently sensitive and specific tests for underlying mechanisms that can predict response to treatment.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Schiller LR. Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine. Am J Gastroenterol. 2018. PMID: 29713027. doi:10.1038/s41395-018-0032-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。